Entity
Stage
A stage is a distinct phase or step in a process, such as a clinical trial, funding round, or review, that marks a significant point of progression or evaluation.
Why it’s in the news: It is in the news due to its role in high-stakes developments, including a failed drug study, a quantum computing competition, and a trade agreement review.
Latest on Stage
- STAT+: Argenx sees unusual setback with failure of late-stage study of drug for autoimmune disease
- DARPA moves Atom Computing, IBM, IonQ and Diraq to final quantum test stage
- From Elvis to Oppenheimer, global ghosts sing noh on the Tokyo theater stage
- Late Stage Funding Dips, Swish Takes On Zomato & More
- USTR initiates next stage of USMCA review
- Why Growth Stage Startup Funding Outpaced Late Stage Investments In Q3
Connections
7 entities linked to Stage across the news graph.